The North Carolina Biotechnology Center has been expanding its support for marine biotechnology during the past decade, and it’s proving to be a great investment for the state.
Jim Shamp writes and edits news and other Web copy, brochures and other internal and external Biotechnology Center materials, and supports the Corporate Communications unit’s marketing and media relations activities.
Shamp joined the Biotechnology Center in 2005, after more than eight years as science and health reporter for the Durham Herald-Sun. He brought to NCBiotech nearly four decades of professional experience in writing, editing, marketing and advertising. This includes some 18 years of newspaper, broadcast, wire service and Web journalism in Illinois, Indiana, Michigan and North Carolina as well as a decade of public-relations activity at major global pharmaceutical companies' headquarters in Michigan and North Carolina. He has also started or been involved in establishing several entrepreneurial ventures.
He participates in a variety of professional, community-service and educational boards and committees, including the National Association of Science Writers.
Shamp holds a B.S. degree in communications from Manchester (Ind.) College (now Manchester University).
-- Shutterstock image
Cempra is a Chapel Hill company that’s developing antibiotics to treat scary bacterial infections.
Besides the four active Nobel Laureates conducting research at Duke and UNC, here are 13 others with N.C. connections who have also won the major global recognition.
When a chorus of cheers accompanies announcements like the $1.85 billion Novo Nordisk expansion in Clayton, the echo is a reminder: it's a team effort.
Two key state funding programs are proving to be a great match to get new North Carolina life science companies off the ground.
Life science entrepreneurs routinely turn to the loan options available from the North Carolina Biotechnology Center after tapping friends, family and credit cards. But many of those same NCBiotech portfolio companies also get much-needed early survival lifelines in the form of grants from the One North Carolina Small Business Fund, managed by the state Department of Commerce’s N.C. Office of Science, Technology and Innovation.
As we weigh the GSK layoff announcement, let’s be glad for what we have and celebrate what’s to come. Sure, things will never be the same. But the fact is, they never were anyway.
Certified Financial Planner Lisa Gabriel provided useful financial tips for people facing job loss during the September 29 Jobs Network gathering at NCBiotech.
The National Institute of Allergy and Infectious Diseases just added $4.1 million to a $22 million, five-year grant made a year ago, to help BioCryst develop an anti-viral drug that could prevent a terrible Ebola outbreak -- next time one happens.
Bob Ingram is one of those rare people who can spin a roomful of people in circles with words. He did it again this week as he accepted a Lifetime Achievement Award from the Triangle Business Journal. And appropriately enough, the room he was spinning was the classy ballroom at the Umstead Hotel in Cary.
The attack of the chikungunya ogre could augur well for Arbovax.
Say that three times fast. Then tell somebody I told you so.